Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Helix BioPharma Corp. (T.HBP) had Return on Tangible Equity of 43.39% for the most recently reported fiscal quarter, ending 2025-10-31.
| Income Statement Financials | |
-- |
|
-0.73M |
|
-- |
|
-- |
|
-- |
|
-0.67M |
|
-- |
|
-0.73M |
|
-0.73M |
|
-0.73M |
|
-0.73M |
|
-0.73M |
|
-0.73M |
|
-0.68M |
|
-0.68M |
|
75.87M |
|
75.87M |
|
-0.01 |
|
-0.01 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
13.74M |
|
-- |
|
-- |
|
-- |
|
2.16M |
|
11.58M |
|
-1.67M |
|
11.58M |
|
76.38M |
|
| Cash Flow Statement Financials | |
-0.88M |
|
-- |
|
1.19M |
|
0.05M |
|
0.36M |
|
0.31M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.23 |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-0.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.27% |
|
|
Return on Tangible Equity |
43.39% |
-5.29% |
|
-6.27% |
|
0.21 |
|
-0.01 |
|
-0.01 |
|